These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9186273)

  • 1. A novel approach to assess changes in endocrine secretion: analysis of GnRH antagonist (Nal-Glu) suppression of gonadotropin release in ovariectomized ewes.
    Normolle DP; Evans NP; Dahl GE; Padmanabhan V
    Eur J Endocrinol; 1997 May; 136(5):519-30. PubMed ID: 9186273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.
    Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF
    J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine control of follicle-stimulating hormone (FSH) secretion: III. Is there a gonadotropin-releasing hormone-independent component of episodic FSH secretion in ovariectomized and luteal phase ewes?
    Padmanabhan V; Brown MB; Dahl GE; Evans NP; Karsch FJ; Mauger DT; Neill JD; Van Cleeff J
    Endocrinology; 2003 Apr; 144(4):1380-92. PubMed ID: 12639921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
    Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
    Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged duration of gonadotropin inhibition by a third generation GnRH antagonist.
    Leal JA; Williams RF; Danforth DR; Gordon K; Hodgen GD
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1325-7. PubMed ID: 3142920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone-dependent regulation of gonadotropin subunit messenger ribonucleic acid levels in the rat.
    Wierman ME; Rivier JE; Wang C
    Endocrinology; 1989 Jan; 124(1):272-8. PubMed ID: 2491805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile administration of gonadotropin-releasing hormone does not alter the follicle-stimulating hormone (FSH) isoform distribution pattern of pituitary or circulating FSH in nutritionally growth-restricted ovariectomized lambs.
    Hassing JM; Kletter GB; I'Anson H; Wood RI; Beitins IZ; Foster DL; Padmanabhan V
    Endocrinology; 1993 Apr; 132(4):1527-36. PubMed ID: 8462450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antigonadotropic activity of three GnRH antagonists (Nal-Glu, Antide and Cetrorelix) in a non-human primate model (Macaca fascicularis).
    Weinbauer GF; Nieschlag E
    Andrologia; 1993; 25(3):141-7. PubMed ID: 8517553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol regulates secretion and pituitary content of the two gonadotropins differentially in female rats: effects of gonadotropin-releasing hormone antagonist.
    Ringstrom SJ; Suter DE; Hostetler JP; Schwartz NB
    Endocrinology; 1992 Jun; 130(6):3122-8. PubMed ID: 1597133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of inhibin and gonadotrophin-releasing hormone in the control of gonadotrophin secretion in the ewe.
    Martin GB; Wallace JM; Taylor PL; Fraser HM; Tsonis CG; McNeilly AS
    J Endocrinol; 1986 Nov; 111(2):287-96. PubMed ID: 3098888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bovine follicular fluid and passive immunization against gonadotropin-releasing hormone (GnRH) on messenger ribonucleic acid for GnRH receptor and gonadotropin subunits in ovariectomized ewes.
    Turzillo AM; Nett TM
    Biol Reprod; 1997 Jun; 56(6):1537-43. PubMed ID: 9166707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH-induced gonadotrophin secretion in ovariectomized Booroola ewes with hypothalamic-pituitary disconnection.
    McNatty KP; Hudson NL; Shaw L; Condell LA; Ball K; Seah SL; Clarke IJ
    J Reprod Fertil; 1991 Mar; 91(2):583-92. PubMed ID: 1901606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acidic mix of FSH isoforms are better facilitators of ovarian follicular maturation and E2 production than the less acidic.
    West CR; Carlson NE; Lee JS; McNeilly AS; Sharma TP; Ye W; Padmanabhan V
    Endocrinology; 2002 Jan; 143(1):107-16. PubMed ID: 11751599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
    Apter D; Bützow TL; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone increases the amount of messenger ribonucleic acid for gonadotropins in ovariectomized ewes after hypothalamic-pituitary disconnection.
    Hamernik DL; Nett TM
    Endocrinology; 1988 Mar; 122(3):959-66. PubMed ID: 2449345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian function in ewes made hypogonadal with GnRH antagonist and stimulated with FSH in the presence or absence of low amplitude LH pulses.
    Campbell BK; Dobson H; Scaramuzzi RJ
    J Endocrinol; 1998 Jan; 156(1):213-22. PubMed ID: 9496251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose administration of the gonadotropin-releasing hormone antagonist, Nal-Lys (antide) to healthy men.
    Bagatell CJ; Conn PM; Bremner WJ
    Fertil Steril; 1993 Oct; 60(4):680-5. PubMed ID: 8405525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.